http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008504328-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2005-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008504328-A |
| titleOfInvention | Abuse prevention oral dosage form containing (1R, 2R) -3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol |
| abstract | The present invention relates to an abuse-preventing oral dosage form having sustained release of (1R, 2R) -3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol for administration once a day. The dosage form comprises an active ingredient and / or one or more pharmaceutically acceptable compounds thereof (A), at least one synthetic and / or natural polymer (C), a delayed release aid, optionally It comprises an additional physiologically acceptable auxiliary substance (B) and optionally a wax (D), characterized in that in each case it exhibits a breaking strength of at least 500 N, preferably at least 750 N. The dosage form contains at least one of the following abuse prevention components (a) to (f). (A) at least one substance that stimulates the nasal canal and / or pharynx, (b) at least one viscosity-increasing agent, (c) at least one antagonist of active ingredients with potential for abuse, (d) at least one Two emetics, (e) at least one pigment as an aversive agent, and (f) at least one bitter substance. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013516985-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008528654-A |
| priorityDate | 2004-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 213.